| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.002 |
| mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | 0.16 | 0.002 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.003 |